Comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following

Tingting Zhang1, Fubin Feng2, Wenge Zhao3

  • 1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China.

Abstract

Insights

Palbociclib plus fulvestrant shows superior progression-free survival compared to other targeted agents for advanced hormone-receptor-positive breast cancer. This combination may be the optimal choice for postmenopausal women after endocrine therapy progression.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Trials

Background:

  • Advanced breast cancer (ABC) treatment requires effective therapies post-endocrine resistance.
  • Hormone-receptor-positive (HR+) and human epidermal growth factor receptor type 2-negative (HER2-) subtypes represent a significant patient population.
  • Identifying optimal targeted agents combined with fulvestrant is crucial for improving patient outcomes.

Purpose of the Study:

  • To conduct a network meta-analysis comparing targeted agents plus fulvestrant against fulvestrant alone.
  • To evaluate the efficacy of palbociclib plus fulvestrant versus alternative targeted therapies in HR+/HER2- ABC.
  • To determine the optimal treatment strategy for patients progressing on prior endocrine therapy.

Main Methods:

  • Network meta-analysis of randomized controlled trials (RCTs) sourced from PubMed, EMBASE, and Cochrane Library.
  • Primary efficacy endpoints included progression-free survival (PFS) and objective response rate (ORR).
  • Surface Under the Cumulative Ranking (SUCRA) analysis was used to rank treatment effectiveness.

Main Results:

  • Palbociclib plus fulvestrant demonstrated superior PFS compared to pictilisib and buparlisib plus fulvestrant (HR=0.62).
  • Ribociclib plus fulvestrant showed no significant difference compared to abemaciclib or palbociclib plus fulvestrant.
  • Abemaciclib, dovitinib, buparlisib, and palbociclib plus fulvestrant significantly improved ORR compared to placebo plus fulvestrant.

Conclusions:

  • Palbociclib plus fulvestrant emerges as a potentially optimal treatment for HR+/HER2- advanced breast cancer patients.
  • This combination offers a promising therapeutic option for postmenopausal women experiencing disease progression after endocrine therapy.
  • Further research may validate these findings and guide personalized treatment approaches.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Group Therapy01:26

Group Therapy

Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
443
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.1K
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
705